Correction: Combining treatments for migraine prophylaxis: the state‑of‑the‑art

Correction: J Headache Pain 25 214 (2024)

https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s10194-024-01925-w

Following publication of this article, the authors have identified an error in Table 2.

Specifically, in row 13 under the Study type ‘Retrospective, cohort study’, the Efficacy result was incorrectly stated as ‘Dual therapy was less effective than erenumab alone’ when it should have been ‘Dual therapy with erenumab was more effective than onabotulinumtoxin A alone’.

The correct and incorrect version of the affected cell is shown below while the full table can be accessed via the online edition of this article.

Correct version

Table 2

Study type	Number of patients	Type of migraine	CGRP treatment	Efficacy results	Safety results
Retrospective, cohort study [141]	187	Chronic migraine	Erenumab (70 or 140 mg)	Dual therapy with erenumab was more effective than onabotulinumtoxin A alone	No relevant side effects were reported

Incorrect version

Table 2

Study type	Number of patients	Type of migraine	CGRP treatment	Efficacy results	Safety results
Retrospective, cohort study [141]	187	Chronic migraine	Erenumab (70 or 140 mg)	Dual therapy was less effective than erenumab alone	No relevant side effects were reported

The original article has been updated.